Dr Todd Dollinger
Chairman; Chief Executive Officer,
The Trendlines Group

Todd Dollinger brings more than four decades of wide-ranging marketing, sales, and entrepreneurial experience to Trendlines – an organization driven by its mission of “investing to improve the human condition.”

He chairs Trendlines Medical Singapore and the investment committees of Trendlines Investments Israel, our Singapore-based Trendlines Agrifood Innovation Centre, and the Trendlines Agrifood Fund. Additionally, Todd is a director and chairs several Trendlines’ portfolio companies. He also serves as a board member of the non-profit Davos-based AO Foundation’s Technology Board which, inter alia, is responsible for allocating Development Incubator funds.

Todd founded The Trendlines Group with Steve Rhodes in 2007 and shares the positions of Chair and CEO of Trendlines with Steve.

In 1991, Todd joined the marketing department of Israeli medical device start-up SRD Medical Ltd. (“SRD”) and went on to become SRD’s CEO. It was at SRD that Todd and Steve met. In 1993, Todd and Steve founded Trendlines International Ltd. They merged the principal consulting activities of Trendlines International Ltd. into The Trendlines Group in 2008.

Under the strength of their 30-year business partnership, Todd and Steve oversaw Trendlines’ IPO on the Singapore Stock Exchange in 2015; and have raised funds around the world for Trendlines, its venture funds, and portfolio companies. They have exited portfolio companies to multinational corporations; taken portfolio companies public; and have expanded the Group’s activities internationally.

Programme Details

Day 2, 13 October 2023 , Friday, 1700 – 1730hrs
Session 8: 13 Oct 2023, Fri, 1600 - 1730hrs
Track : Track 4B: Revolutionising Healthcare: Exploring Medtech, Biotech innovations for a Healthier Future (GARNET 212 – 213)
Topic : Panel Discussion and Q&A